GLPG Galapagos NV ADR

USD 32.20 -0.75 -2.276176
Icon

Galapagos NV ADR (GLPG) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Under-perform

Average Analyst
Rating
stockTargetAdvisor

Under-perform

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 32.20

-0.75 (-2.28)%

USD 2.17B

0.30M

USD 34.50(+7.14%)

USD 60.00 (+86.34%)

Icon

GLPG

Galapagos NV ADR (USD)
COMMON STOCK | NSD
USD 32.20
0.00 0
Take a Tour
stockTargetAdvisor

Under-perform

Average Analyst
Rating
stockTargetAdvisor

Under-perform

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 2.17B

USD 60.00 (+86.34%)

USD 32.20

Galapagos NV ADR (GLPG) Stock Forecast

Show ratings and price targets of :
USD 34.50
(+7.14%)

Based on the Galapagos NV ADR stock forecast from 2 analysts, the average analyst target price for Galapagos NV ADR is USD 34.50 over the next 12 months. Galapagos NV ADR’s average analyst rating is Under-perform. Stock Target Advisor’s own stock analysis of Galapagos NV ADR is Slightly Bullish , which is based on 8 positive signals and 6 negative signals. At the last closing, Galapagos NV ADR’s stock price was USD 32.20. Galapagos NV ADR’s stock price has changed by -3.65% over the past week, -10.75% over the past month and -11.78% over the last year.

No recent analyst target price found for Galapagos NV ADR
No recent average analyst rating found for Galapagos NV ADR

Company Overview Galapagos NV ADR

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of"various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the tr...Read More

https://www.glpg.com

Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800

0

December

USD

USA

Adjusted Closing Price for Galapagos NV ADR (GLPG)

Loading...

Unadjusted Closing Price for Galapagos NV ADR (GLPG)

Loading...

Share Trading Volume for Galapagos NV ADR Shares

Loading...

Compare Performance of Galapagos NV ADR Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for GLPG

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Galapagos NV ADR (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing GLPG

Symbol Name GLPG's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Galapagos NV ADR (GLPG) Stock

Based on ratings from 2 analysts Galapagos NV ADR's stock is Under-perform. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has buy, 1 sell and 1 hold ratings.

Unfortunately we do not have enough data on GLPG's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for GLPG is USD 34.50 over the next 12 months. The maximum analyst target price is USD 38 while the minimum anlayst target price is USD 31.

GLPG stock's Price/Earning ratio is 364.19. Our analysis grades GLPG stock's Price / Earning ratio at F. This means that GLPG stock's Price/Earning ratio is above 95% of the stocks in the Biotechnology sector in the NSD exchange. Based on this GLPG may be a overvalued for its sector.

The last closing price of GLPG's stock was USD 32.20.

The most recent market capitalization for GLPG is USD 2.17B.

Based on targets from 2 analysts, the average taret price for GLPG is projected at USD 34.50 over the next 12 months. This means that GLPG's stock price may go up by +7.14% over the next 12 months.

We can't find any ETFs which contains Galapagos NV ADR's stock.

As per our most recent records Galapagos NV ADR has 0 Employees.

Galapagos NV ADR's registered address is Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800. You can get more information about it from Galapagos NV ADR's website at https://www.glpg.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...